Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease.

Asthma and chronic obstructive pulmonary disease (COPD) are pathologically distinct in terms of their predominant inflammatory cells and structural alterations (i.e., remodeling). However, there are many cases of functional and pathologic overlap, supporting the author's view that use of the terms asthma or COPD is oversimplistic and fails to identify the range of phenotypes that exist. In general, there is epithelial fragility and thickening of the reticular basement membrane, even in mild asthma; increased airway smooth muscle mass, hypertrophy of mucus-secreting glands, increased vascularity, greater numbers of fibroblasts, and increased deposition of collagen in severe asthma and COPD; and mucous metaplasia, squamous metaplasia, and parenchymal destruction in COPD. Because of increased neutrophilia, patterns of inflammation become similar when exacerbations of asthma and COPD result in hospitalization. Moreover, in mild COPD, exacerbations of bronchitis are associated with mucosal eosinophilia and upregulation of RANTES, two features normally associated with asthma. The overlap may also be seen in intermediate thickening of the reticular basement membrane and eosinophilia in patients with COPD who demonstrate reversibility to oral steroid. Importantly, a recent study of "eosinophilic bronchitis" demonstrates a thickened reticular basement membrane and challenges our current concept of the histopathologic distinctions between asthma and COPD.

[1]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[2]  P. Woodruff,et al.  Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. , 2004, American journal of respiratory and critical care medicine.

[3]  S. Holgate,et al.  The airway epithelium: Structural and functional properties in health and disease , 2003, Respirology.

[4]  R. Atmar,et al.  Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[5]  B. Beghé,et al.  Airway inflammation in childhood asthma. , 2003, American journal of respiratory and critical care medicine.

[6]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[7]  K. Aoshiba,et al.  Alveolar wall apoptosis causes lung destruction and emphysematous changes. , 2003, American journal of respiratory cell and molecular biology.

[8]  B. Beghé,et al.  Increased proportion of CD8+ T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD. , 2003, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[9]  L. Corbetta,et al.  Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[10]  A. Bush,et al.  Early thickening of the reticular basement membrane in children with difficult asthma. , 2003, American journal of respiratory and critical care medicine.

[11]  R. Pauwels,et al.  Gene expression and immunolocalization of 15-lipoxygenase isozymes in the airway mucosa of smokers with chronic bronchitis. , 2002, American journal of respiratory cell and molecular biology.

[12]  S. Wenzel,et al.  Transbronchial biopsy as a tool to evaluate small airways in asthma , 2002, European Respiratory Journal.

[13]  A. James,et al.  Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma , 2002, Thorax.

[14]  B. Beghé,et al.  Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. , 2002, American journal of respiratory and critical care medicine.

[15]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[16]  L. Fabbri,et al.  Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[17]  D. Johns,et al.  Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma , 2002, Thorax.

[18]  K. J. Macleod,et al.  Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma , 2002, Thorax.

[19]  P. Jeffery Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease. , 2001, Novartis Foundation symposium.

[20]  R. Pauwels,et al.  Interleukin-4 and interleukin-5 gene expression and inflammation in the mucus-secreting glands and subepithelial tissue of smokers with chronic bronchitis. Lack of relationship with CD8(+) cells. , 2001, American journal of respiratory and critical care medicine.

[21]  M. Roth,et al.  Mechanisms of airway remodeling. Airway smooth muscle. , 2001, American journal of respiratory and critical care medicine.

[22]  P. Jeffery Remodeling in asthma and chronic obstructive lung disease. , 2001, American journal of respiratory and critical care medicine.

[23]  J. Faul,et al.  Activated, cytotoxic CD8(+) T lymphocytes contribute to the pathology of asthma death. , 2001, American journal of respiratory and critical care medicine.

[24]  P. Paré,et al.  Amplification of inflammation in emphysema and its association with latent adenoviral infection. , 2001, American journal of respiratory and critical care medicine.

[25]  M. Tamm,et al.  Airway smooth muscle cell proliferation is increased in asthma. , 2001, American journal of respiratory and critical care medicine.

[26]  L. Fabbri,et al.  Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. , 2001, American journal of respiratory and critical care medicine.

[27]  L. Fabbri,et al.  Cellular and structural bases of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[28]  C. Armour,et al.  Factors controlling transduction signaling and proliferation of airway smooth muscle , 2001, Current allergy and asthma reports.

[29]  J. Fahy,et al.  Epithelial desquamation in asthma. , 2000, American journal of respiratory and critical care medicine.

[30]  K. Sekizawa,et al.  Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. , 2001, American journal of respiratory cell and molecular biology.

[31]  D. Lúdvíksdóttir,et al.  Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. , 2000, American journal of respiratory and critical care medicine.

[32]  P. Howarth,et al.  Involvement of the epidermal growth factor receptor in epithelial repair in asthma , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  V. Tkachuk,et al.  The Chemotactic Action of Urokinase on Smooth Muscle Cells Is Dependent on Its Kringle Domain , 2000, The Journal of Biological Chemistry.

[34]  R. Djukanović,et al.  Bronchial angiogenesis in severe glucocorticoid-dependent asthma. , 2000, The European respiratory journal.

[35]  P. Jeffery,et al.  Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture. , 2000, Chest.

[36]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[37]  Wood,et al.  Cigarette smoke extract decreases the expression of vascular endothelial growth factor by cultured cells and triggers apoptosis of pulmonary endothelial cells , 2000, Chest.

[38]  L. Fabbri,et al.  Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. , 2000, American journal of respiratory and critical care medicine.

[39]  T. Seemungal,et al.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.

[40]  J. Crapo,et al.  Cellular and connective tissue changes in alveolar septal walls in emphysema. , 1999, American journal of respiratory and critical care medicine.

[41]  C. Plopper,et al.  The attenuated fibroblast sheath of the respiratory tract epithelial-mesenchymal trophic unit. , 1999, American journal of respiratory cell and molecular biology.

[42]  K. Chung,et al.  Neutrophilic inflammation in severe persistent asthma. , 1999, American journal of respiratory and critical care medicine.

[43]  P. Saldiva,et al.  Elastosis and fragmentation of fibers of the elastic system in fatal asthma. , 1999, American journal of respiratory and critical care medicine.

[44]  L. Fabbri,et al.  CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[45]  V. Peinado,et al.  Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[46]  J. Bousquet,et al.  Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. , 1999, The Journal of allergy and clinical immunology.

[47]  J. Vandenbroucke,et al.  Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.

[48]  F. Thien,et al.  Vascularity in asthmatic airways: relation to inhaled steroid dose. , 1999, Thorax.

[49]  S. Wenzel,et al.  Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. , 1998, American journal of respiratory and critical care medicine.

[50]  I. Adcock,et al.  Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. , 1998, American journal of respiratory and critical care medicine.

[51]  P. Jeffery The Development of Large and Small Airways , 1998 .

[52]  L. Fabbri,et al.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[53]  Y. Nakamura,et al.  Expression of growth factors and remodelling of the airway wall in bronchial asthma. , 1998, Thorax.

[54]  S. Wenzel,et al.  Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. , 1997, American journal of respiratory and critical care medicine.

[55]  R. Martin,et al.  Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. , 1997, American journal of respiratory cell and molecular biology.

[56]  P. O'Byrne,et al.  Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. , 1997, American journal of respiratory cell and molecular biology.

[57]  J. Bousquet,et al.  Corticosteroid reversibility in COPD is related to features of asthma. , 1997, American journal of respiratory and critical care medicine.

[58]  N. Charan,et al.  Bronchial vascular congestion and angiogenesis. , 1997, The European respiratory journal.

[59]  P. Jeffery,et al.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.

[60]  A. James,et al.  Bronchial blood vessel dimensions in asthma. , 1997, American journal of respiratory and critical care medicine.

[61]  J. Hogg,et al.  The pathology of asthma , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[62]  S. Durham,et al.  Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. , 1997, American journal of respiratory cell and molecular biology.

[63]  K. Shirato,et al.  Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. , 1996, The European respiratory journal.

[64]  L. Fabbri,et al.  Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. , 1996, Thorax.

[65]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[66]  P. W. Johnston,et al.  Airway and lung elastic fibre is not reduced in asthma nor in asthmatics following corticosteroid treatment. , 1995, The European respiratory journal.

[67]  G. Cox,et al.  Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. , 1995, Journal of immunology.

[68]  R. Djukanović,et al.  15-lipoxygenase immunoreactivity in normal and in asthmatic airways. , 1995, American journal of respiratory and critical care medicine.

[69]  L. Fabbri,et al.  Airway eosinophilia in chronic bronchitis during exacerbations. , 1994, American journal of respiratory and critical care medicine.

[70]  D Lamb,et al.  Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. , 1994, Thorax.

[71]  P. Paré,et al.  Small airways dimensions in asthma and in chronic obstructive pulmonary disease. , 1993, The American review of respiratory disease.

[72]  M. Ebina,et al.  Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. , 1993, The American review of respiratory disease.

[73]  J. Hogg,et al.  Functional significance of increased airway smooth muscle in asthma and COPD. , 1993, Journal of applied physiology.

[74]  A. James,et al.  The structure of large and small airways in nonfatal and fatal asthma. , 1993, The American review of respiratory disease.

[75]  M. Ebina,et al.  Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. , 1992, Chest.

[76]  P. Jeffery Pathology of asthma. , 1992, British medical bulletin.

[77]  J. Hogg,et al.  The comparative mechanics and morphology of airways in asthma and in chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[78]  P. Howarth,et al.  Myofibroblasts and subepithelial fibrosis in bronchial asthma. , 1990, American journal of respiratory cell and molecular biology.

[79]  P. Paré,et al.  Small airway dimensions in smokers with obstruction to airflow. , 1990, The American review of respiratory disease.

[80]  H. Yaegashi,et al.  Distribution of smooth muscles along the bronchial tree. A morphometric study of ordinary autopsy lungs. , 1990, The American review of respiratory disease.

[81]  T. Bai,et al.  Abnormalities in airway smooth muscle in fatal asthma. , 1990, The American review of respiratory disease.

[82]  A. Wardlaw,et al.  Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. , 1989, The American review of respiratory disease.

[83]  S. Rennard,et al.  Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. , 1989, The American review of respiratory disease.

[84]  S. Holgate,et al.  Cellular events in the bronchi in mild asthma and after bronchial provocation. , 1989, The American review of respiratory disease.

[85]  J. Hogg,et al.  Pulmonary vascular structure and function in chronic obstructive pulmonary disease. , 1988, Thorax.

[86]  J. Hogg,et al.  Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: relationship to lung function. , 1987, Thorax.

[87]  Snider Gl Chronic obstructive pulmonary disease--a continuing challenge. , 1986 .

[88]  R. Sobonya Quantitative structural alterations in long-standing allergic asthma. , 1984, The American review of respiratory disease.

[89]  J Dosman,et al.  The relations between structural changes in small airways and pulmonary-function tests. , 1978, The New England journal of medicine.

[90]  E. Middleton,et al.  Allergy, principles and practice , 1978 .

[91]  J. Anderson,et al.  A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema , 1969, Thorax.

[92]  L. Reid,et al.  The Pathology of Chronic Bronchitis , 1956, The British journal of clinical practice.

[93]  L. Michaels,et al.  Bronchial Biopsy in Chronic Bronchitis and Asthma , 1960, Tip Fakultesi mecmuasi.